NCT03655964View on ClinicalTrials.gov

Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 20, 2018

Primary Completion Date

August 20, 2019

Study Completion Date

August 20, 2019

Conditions
Stroke, Ischemic
Interventions
DRUG

Olmesartan

At Day 4 of stroke onset, patients with clinic BP \>160/100 mmHg will receive olmesartan 20 mg once daily until Day 7 of stroke onset

DRUG

Nebivolol

At Day 4 of stroke onset, patients with clinic BP \>160/100 mmHg will receive nebivolol 5mg once daily until Day 7 of stroke onset

OTHER

No antihypertensive treatment

Patients will be left without treatment

Trial Locations (1)

54621

AHEPA University Hospital, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER

NCT03655964 - Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic Stroke | Biotech Hunter | Biotech Hunter